Manning had been listed as questionable on Wednesday, but coach Steve Sarkisian also said his quarterback was practicing and making “good progress” during the week.

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), ...

According to sources, during a recent weekly crime review meeting, Commissioner Golchha observed that several PCR-reported crime calls were being “burped” or dismissed without being formally ...

The blast occurred while personnel were handling the explosive material that had been brought from Haryana's Faridabad ...

The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Novartis' GanLum met key Phase 3 goals, showing strong efficacy and safety in malaria patients, including against resistant ...

The COVID-19 narrative has been dealt a significant blow by a groundbreaking study emerging from Germany, challenging the credibility of PCR testing that was heralded as the cornerstone of pandemic ...

A new malaria drug, Ganaplacide/Lumefantrine, shows over 97% cure rates in trials. This treatment is effective even where ...

In this Q&A, Pratt discusses a recent study comparing multiplex droplet digital PCR (ddPCR) with traditional quantitative PCR ...

A new Rasmussen Reports survey reveals an unsettling reality: nearly one-third of American adults say someone they know died of COVID-19 while hospitalized, and almost half believe hospital treatment ...